byiShook Opinion
Feb 4, 2025 - 11:25
Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat. The post Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? appeared first on Investor's Business Daily.
Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.
The post Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? appeared first on Investor's Business Daily.